Symbols

MTLS

Materialise·NASDAQ

--(--)

MTLS fundamentals

MTLS Q4 2025 Earnings

Materialise (MTLS) released its earnings on Feb 19, 2026: revenue was 82.69M (YoY +21.62%), missed estimates; EPS was 0.1296 (YoY +150.19%), beat estimates.

Revenue / YoY

82.69M

+21.62%

EPS / YoY

0.1296

+150.19%

Report date

Feb 19, 2026

MTLS Earnings Call Summary for Q4,2025

Key Takeaways:

Medical Dominance: Medical segment grew 16% YoY in Q4, accounting for 53% of Q4 revenue.
Software Transformation: Mimics Flow 2.0 shifts to subscription model, with 82% of Software revenue recurring.
Manufacturing Challenges: Segment revenue down 2% YoY in Q4, with 2026 outlook cautious due to industrial weakness.
Financial Strength: €134 million cash on hand, €6.2 million Q4 net profit (€0.11/share), up 124% YoY.
Strategic Focus: €30 million buyback program and dual listing to expand European investor access.

Earnings

EPS

Revenue

Revenue & Expenses

MTLS has released its 2025 Q4 earnings report, with revenue of 82.34M, reflecting a YoY change of 21.12%, and net profit of 7.28M, showing a YoY change of 142.05%. The Sankey diagram below clearly presents MTLS's revenue sources and cost distribution.

Key Indicators

Materialise (MTLS) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Materialise (MTLS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Materialise (MTLS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Materialise (MTLS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown